Systemic candidiasis in intensive care units: A multicenter, matched-cohort study

被引:135
作者
Leleu, G
Aegerter, P
Guidet, B
机构
[1] Hop St Antoine, Med Intens Care Unit, F-75012 Paris, France
[2] Hop Ambroise Pare, Dept Biostat, Boulogne, France
[3] Hop St Antoine, Med Intens Care Unit, F-75571 Paris, France
关键词
D O I
10.1053/jcrc.2002.35815
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To determine the impact of systemic candidiasis on the mortality and length of hospital stay of intensive care unit (ICU) patients and the associated workload. Design: Multicenter, retrospective, matched-cohort study. Setting: Data were retrieved from a computerized database that prospectively collected clinical data submitted by 32 ICUs in the Paris, France area. Patients: A total of 149 stays with systemic candidiasis, including 104 candidemia, on ICU admission were identified in a 3-year period (1995-1997) among 49,063 admissions (3 per 1,000 admission). A total of 121 cases were matched with patients with no evidence of systemic Candida infection during the hospitalization period under study (same ICU, date of ICU admission, age, sex, simplified acute physiology score (SAPS II), location of the patient before admission, type of admission). Results: Patients with systemic candidiasis had longer ICU length of stays than controls (25 vs 10 d; P = .001) with a relative risk for death of 2.27 (95% confidence interval, 1.64-3.11; P = .001). There was no difference between patients with systemic candidiasis with or without positive blood culture. Conclusions: Systemic Candida infections increased mortality and morbidity in severely ill patients. Optimizing management of such infections is imperative. Copyright 2002, Elsevier Science (USA). All rights reserved.
引用
收藏
页码:168 / 175
页数:8
相关论文
共 31 条
[1]   The epidemiology of hematogenous candidiasis caused by different Candida species [J].
AbiSaid, D ;
Anaissie, E ;
Uzun, O ;
Raad, I ;
Pinzcowski, H ;
Vartivarian, S .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (06) :1122-1128
[2]  
Aegerter P, 1998, REV EPIDEMIOL SANTE, V46, P226
[3]  
BECKSAGUE CM, 1993, J INFECT DIS, V167, P1247, DOI 10.1093/infdis/167.5.1247
[4]   Risk factors for candidal bloodstream infections in surgical intensive care unit patients: The NEMIS Prospective Multicenter Study [J].
Blumberg, HM ;
Jarvis, WR ;
Soucie, JM ;
Edwards, JE ;
Patterson, JE ;
Pfaller, MA ;
Rangel-Frausto, MS ;
Rinaldi, MG ;
Saiman, L ;
Wiblin, RT ;
Wenzel, RP .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (02) :177-186
[5]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[6]  
*COMM EV SOC REAN, 1986, REAN SOINS INTENS ME, V2, P219
[7]   Nosocomial bloodstream infections in United States hospitals: A three-year analysis [J].
Edmond, MB ;
Wallace, SE ;
McClish, DK ;
Pfaller, MA ;
Jones, RN ;
Wenzel, RP .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (02) :239-244
[8]   INVASIVE CANDIDA INFECTIONS - EVOLUTION OF A FUNGAL PATHOGEN [J].
EDWARDS, JE .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (15) :1060-1062
[9]   CANDIDEMIA IN A TERTIARY CARE HOSPITAL - EPIDEMIOLOGY, RISK-FACTORS, AND PREDICTORS OF MORTALITY [J].
FRASER, VJ ;
JONES, M ;
DUNKEL, J ;
STORFER, S ;
MEDOFF, G ;
DUNAGAN, WC .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (03) :414-421
[10]   Epidemiology of nosocomial fungal infections [J].
Fridkin, SK ;
Jarvis, WR .
CLINICAL MICROBIOLOGY REVIEWS, 1996, 9 (04) :499-&